logo
Select company
Select metric
1.74%Capital Expenditures Margin
VS
Market
68
Sector
64
Industry
63
History
70
$ 9.92Close
$ 4.58 - $ 18.35 52-Week Range
Ticker Information

Ticker

PRTA

Company Name

PROTHENA CORP PUBLIC LTD CO

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PROTHENA CORP PUBLIC LTD CO - Capital Expenditures Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PRTA - CapEx % Historical data
DateCapital ExpenditureCapital Expenditures MarginRevenues
6/30/2025$ 180K1.74%$ 10.34M
3/31/2025$ 237K0.17%$ 137.94M
12/31/2024$ 298K0.22%$ 135.16M
9/30/2024$ 1.77M1.33%$ 133.35M
6/30/2024$ 2.2M1.01%$ 217.25M
3/31/2024$ 2.83M3.17%$ 89.25M
12/31/2023$ 2.77M3.03%$ 91.37M
9/30/2023$ 1.41M1%$ 140.98M
6/30/2023$ 1.1M1.91%$ 57.63M
3/31/2023$ 490K0.89%$ 54.92M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROTHENA CORP PUBLIC LTD CO's latest trailing twelve months (TTM) CapEx % stands at 33.51%.
  • Over the past 5 years, PROTHENA CORP PUBLIC LTD CO's average CapEx % has been 5.55%.
  • The median CapEx % for PROTHENA CORP PUBLIC LTD CO during this period was 1.01%
  • PROTHENA CORP PUBLIC LTD CO reached its highest CapEx % over the past 5 years at 33.51%.
  • The lowest CapEx % recorded by PROTHENA CORP PUBLIC LTD CO in the same timeframe 0.15%

PROTHENA CORP PUBLIC LTD CO's CapEx % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx % Benchmarks
CompanyCapEx %
TNXP : TONIX PHARMACEUTICALS HOLDING CORP 5.54%CAPR : CAPRICOR THERAPEUTICS INC 25.27%LCTX : LINEAGE CELL THERAPEUTICS INC 5.39%OCGN : OCUGEN INC 12.18%TVRD : TVARDI THERAPEUTICS INC -ABSI : ABSCI CORP -RLAY : RELAY THERAPEUTICS INC 7.62%SRZN : SURROZEN INC 0.6%PRME : PRIME MEDICINE INC 142.35%VSTM : VERASTEM INC -

Definition of Capital Expenditures Margin

[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
CapEx / Revenues
(=) CapEx %
CapEx % for PROTHENA CORP PUBLIC LTD CO is calculated as follows: CapEx [ $ 251K ] / Revenues [ $ 749K ]
(=) CapEx % [ 33.51% ]

PRTA - Capital Expenditures Margin, Last 5 years

0.15%

Minimum

Sep 30, 2021

33.51%

Maximum

Sep 30, 2020

5.55%

Average

1.01%

Median

CapEx % Benchmark Analysis

The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.46% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
filtered constituents2.85K
min0%
max15.04%
average3.46%
median2.43%
std3.27%